Saturday, February 4, 2023

Pakistan receives 3.7 million Pfizer doses from US

3.7 million Pfizer COVID-19 doses receieved via COVAX facility

The government of Pakistan received 3.7 million doses of Pfizer COVID-19 vaccine from the United States on August 26 morning via the COVAX global distribution program.

These doses were received in addition to the 5.5 million Moderna vaccine doses, bringing the total number of doses sent from the United States to Pakistan to over 9.2 million. 

“This donation is part of the 500 million Pfizer doses the United States purchased this summer to deliver to 92 countries and economies worldwide, including Pakistan, to fulfill President Joe Biden’s commitment to provide safe and effective vaccines around the world and supercharge the global fight against the pandemic” the official statement reads.

“There is an urgency, now more than ever, to put an end to this devastating pandemic, and Pakistan and the United States are continuing to work together to achieve that goal,” said U.S. Embassy Chargé d’affaires Angela P. Aggeler. 

“The United States is proud to partner with the Pakistani people to defeat COVID-19.  Together, we will continue to build a world that is safer and more secure against the threat of infectious disease.” 

Since the start of the pandemic, the United States has delivered more than $63 million in COVID-19 assistance to the Government of Pakistan s to improve infection prevention and control, enhance patient care, expand laboratory testing, and support frontline healthcare workers.

Pakistan has so far administered 49.8 million doses. At least 14.8 million are fully vaccinated while 39.2 million have received at least one dose.

Pakistan has largely relied on Chinese vaccines to vaccinate its citizens. However, many Pakistanis working in the Middle East and Europe and could not return to these countries where Chinese vaccines were not approved yet. Pfizer and Moderna vaccines are being used in the majority of European nations.

The news of shipment comes after US Food and Drug Administration (FDA) gave full approval to Pfizer’s two-dose COVID-19 vaccine for those aged 16 and older.

The vaccine had initially been given emergency use authorization.

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected

- Advertisement -spot_img

Latest Articles